Morgan Stanley
CSCI

Morgan Stanley’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.7K Sell
500
-2
-0.4% -$7 ﹤0.01% 7257
2025
Q1
$1.42K Buy
502
+102
+26% +$288 ﹤0.01% 7237
2024
Q4
$1.11K Buy
+400
New +$1.11K ﹤0.01% 7261
2024
Q3
Sell
-10
Closed -$44 8046
2024
Q2
$44 Sell
10
-16,170
-100% -$71.1K ﹤0.01% 7542
2024
Q1
$35.4K Sell
16,180
-15,980
-50% -$35K ﹤0.01% 6337
2023
Q4
$59.8K Buy
32,160
+16,080
+100% +$29.9K ﹤0.01% 6328
2023
Q3
$40.2K Sell
16,080
-133
-0.8% -$333 ﹤0.01% 6257
2023
Q2
$41.7K Buy
16,213
+51
+0.3% +$131 ﹤0.01% 6282
2023
Q1
$42.3K Buy
16,162
+1,750
+12% +$4.59K ﹤0.01% 6338
2022
Q4
$45.8K Buy
14,412
+562
+4% +$1.79K ﹤0.01% 6333
2022
Q3
$53K Sell
13,850
-288,750
-95% -$1.1M ﹤0.01% 6385
2022
Q2
$59K Buy
302,600
+246,600
+440% +$48.1K ﹤0.01% 6543
2022
Q1
$20K Buy
56,000
+34,324
+158% +$12.3K ﹤0.01% 7158
2021
Q4
$7K Sell
21,676
-4,124
-16% -$1.33K ﹤0.01% 7580
2021
Q3
$19K Sell
25,800
-3,300
-11% -$2.43K ﹤0.01% 7121
2021
Q2
$25K Sell
29,100
-12,000
-29% -$10.3K ﹤0.01% 6930
2021
Q1
$47K Sell
41,100
-486,745
-92% -$557K ﹤0.01% 6377
2020
Q4
$224K Sell
527,845
-596,153
-53% -$253K ﹤0.01% 5535
2020
Q3
$395K Buy
1,123,998
+286,853
+34% +$101K ﹤0.01% 4755
2020
Q2
$671K Sell
837,145
-20,389
-2% -$16.3K ﹤0.01% 4444
2020
Q1
$439K Buy
857,534
+89,792
+12% +$46K ﹤0.01% 4454
2019
Q4
$699K Buy
767,742
+36,563
+5% +$33.3K ﹤0.01% 4747
2019
Q3
$753K Buy
731,179
+43,355
+6% +$44.6K ﹤0.01% 4466
2019
Q2
$2.03M Sell
687,824
-14,453
-2% -$42.7K ﹤0.01% 3754
2019
Q1
$3.27M Sell
702,277
-5,137
-0.7% -$23.9K ﹤0.01% 3128
2018
Q4
$2.08M Buy
707,414
+330,807
+88% +$973K ﹤0.01% 3731
2018
Q3
$656K Buy
376,607
+127,540
+51% +$222K ﹤0.01% 4829
2018
Q2
$487K Buy
249,067
+108,600
+77% +$212K ﹤0.01% 5121
2018
Q1
$205K Buy
140,467
+55,676
+66% +$81.3K ﹤0.01% 5456
2017
Q4
$200K Buy
84,791
+48,416
+133% +$114K ﹤0.01% 5405
2017
Q3
$75K Buy
36,375
+1,850
+5% +$3.81K ﹤0.01% 5656
2017
Q2
$34K Buy
34,525
+800
+2% +$788 ﹤0.01% 5960
2017
Q1
$102K Buy
33,725
+2,800
+9% +$8.47K ﹤0.01% 5593
2016
Q4
$112K Buy
30,925
+9,800
+46% +$35.5K ﹤0.01% 5536
2016
Q3
$73K Buy
21,125
+12,966
+159% +$44.8K ﹤0.01% 5437
2016
Q2
$26K Buy
8,159
+5,274
+183% +$16.8K ﹤0.01% 5764
2016
Q1
$10K Buy
2,885
+2,084
+260% +$7.22K ﹤0.01% 6138
2015
Q4
$4K Sell
801
-3,838
-83% -$19.2K ﹤0.01% 6420
2015
Q3
$0 Buy
4,639
+177
+4% ﹤0.01% 6743
2015
Q2
$1K Sell
4,462
-6,735
-60% -$1.51K ﹤0.01% 6583
2015
Q1
$6K Sell
11,197
-76,360
-87% -$40.9K ﹤0.01% 6313
2014
Q4
$53K Buy
87,557
+76,360
+682% +$46.2K ﹤0.01% 5802
2014
Q3
$15K Sell
11,197
-1,000
-8% -$1.34K ﹤0.01% 6094
2014
Q2
$14K Sell
12,197
-15,801
-56% -$18.1K ﹤0.01% 6111
2014
Q1
$33K Sell
27,998
-5,570
-17% -$6.57K ﹤0.01% 5845
2013
Q4
$46K Buy
33,568
+20,800
+163% +$28.5K ﹤0.01% 5622
2013
Q3
$19K Sell
12,768
-166
-1% -$247 ﹤0.01% 5285
2013
Q2
$24K Buy
+12,934
New +$24K ﹤0.01% 5264